HQY:NSD-HealthEquity Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 100.58

Change

0.00 (0.00)%

Market Cap

USD 9.51B

Volume

0.77M

Analyst Target

USD 62.31
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-09 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 39.59B
TEM Tempus AI, Inc. Class A Common..

N/A

USD 9.00B
WAY Waystar Holding Corp. Common S..

N/A

USD 4.47B
BTSG BrightSpring Health Services, ..

N/A

USD 3.36B
PRVA Privia Health Group Inc

N/A

USD 2.72B
PINC Premier Inc

N/A

USD 1.93B
CERT Certara Inc

N/A

USD 1.93B
GDRX Goodrx Holdings Inc

N/A

USD 1.91B
SDGR Schrodinger Inc

N/A

USD 1.87B
OMCL Omnicell Inc

N/A

USD 1.78B

ETFs Containing HQY

FESM Fidelity Covington Trust 0.69 % 0.00 %

N/A

USD 2.22B
RSSL Global X Funds 0.36 % 0.00 %

N/A

USD 1.55B
R2US:SW SPDR® Russell 2000 US Sm.. 0.34 % 0.00 %

N/A

USD 4.92B
XRS2:F Xtrackers (IE) Public Lim.. 0.34 % 0.00 %

N/A

USD 1.19B
XRS2:SW Xtrackers Russell 2000 UC.. 0.34 % 0.00 %

N/A

USD 2.15B
ITWO Proshares Russell 2000 Hi.. 0.32 % 0.00 %

N/A

USD 0.05B
HDG ProShares Hedge Replicati.. 0.00 % 0.95 %

N/A

USD 0.02B
IWM iShares Russell 2000 ETF 0.00 % 0.19 %

N/A

N/A
VRTGX Vanguard Russell 2000 Gro.. 0.00 % 0.00 %

N/A

USD 1.19B
VRTIX Vanguard Russell 2000 Ind.. 0.00 % 0.00 %

N/A

USD 10.02B
URTY ProShares UltraPro Russel.. 0.00 % 0.95 %

N/A

USD 0.41B
UWM ProShares Ultra Russell20.. 0.00 % 0.95 %

N/A

USD 0.43B
VTWG Vanguard Russell 2000 Gro.. 0.00 % 0.20 %

N/A

USD 1.05B
VTWO Vanguard Russell 2000 Ind.. 0.00 % 0.15 %

N/A

USD 11.80B
R2SC:LSE SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 4.81B
R2US:LSE SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 4.74B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 2.15B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 2.11B
NSCS Nuveen Small Cap Select E.. 0.00 % 0.00 %

N/A

USD 8.63M

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.83% 68% D+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.83% 68% D+ 77% C+
Trailing 12 Months  
Capital Gain 24.04% 83% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.04% 81% B- 80% B-
Trailing 5 Years  
Capital Gain 77.64% 91% A- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.64% 86% B+ 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.51% 79% B- 65% D
Dividend Return 12.51% 77% C+ 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.58% 83% B 71% C-
Risk Adjusted Return 50.89% 92% A 78% C+
Market Capitalization 9.51B 98% N/A 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.